Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

You may be eligible if

• Histologically or cytologically proven, newly diagnosed primary bronchogenic non-small cell lung cancer
• Measurable or evaluable tumour on chest X-ray or CT scan.
• No multiple ipsilateral or contralateral parenchymal tumours
• Stage I(exceptT1N0),II,IIIa disease as shown by PET-CT